Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 10, 2010, Pages

  Butz, Henriett ^a   Likó, István ^b   Czirják, Sándor ^c   Igaz, Péter ^a   Khan, Mohammed Munayem ^d   Zivkovic, Vladimir ^e   Bálint, Katalin ^a   Korbonits, Márta ^d   Rácz, Károly ^a   Patócs, Attila ^a,f  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b GEDEON RICHTER LTD   (Hungary)

^c NATIONAL INSTITUTE OF NEUROSURGERY   (Hungary)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY OF BELGRADE   (Serbia)

^f INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MESSENGER RNA; MICRORNA; NUCLEAR PROTEIN; PROLACTIN; UNCLASSIFIED DRUG; WEE1 KINASE;

5' UNTRANSLATED REGION; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; DOWN REGULATION; ENZYME ASSAY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; HYPOPHYSIS ADENOMA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 77957782177     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0581     Document Type: Article

References (40)

1. Daly AF, Burlacu MC, Livadariu E, Beckers A 2007 The epidemiology and management of pituitary incidentalomas. Horm Res 68(Suppl 5):195-198
2. Dworakowska D, Grossman AB 2009 The pathophysiology of pituitary adenomas. Best Pract Res Clin Endocrinol Metab 23:525-541
3. Hibberts NA, Simpson DJ, Bicknell JE, Broome JC, Hoban PR, Clayton RN, Farrell WE 1999 Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors. Clin Cancer Res 5:2133-2139
4. Pierantoni GM, Finelli P, Valtorta E, Giardino D, Rodeschini O, Esposito F, Losa M, Fusco A, Larizza L 2005 High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy. Endocr Relat Cancer 12:867-874
5. Backert S, Gelos M, Kobalz U, Hanski ML, Böhm C, Mann B, Lövin N, Gratchev A, Mansmann U, Moyer MP, Riecken EO, Hanski C 1999 Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array. Int J Cancer 82:868-874
6. McGowan CH, Russell P 1993 Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. EMBO J 12:75-85
7. Yoshida T, Tanaka S, Mogi A, Shitara Y, Kuwano H 2004 The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer. Ann Oncol 15:252-256
8. Lee RC, Ambros V 2001 An extensive class of small RNAs in Caenorhabditis elegans. Science 294:862-864
9. Deng S, Calin GA, Croce CM, Coukos G, Zhang L 2008 Mechanisms of microRNA deregulation in cancer. Cell Cycle 7:3729-3741
10. Amaral FC, Torres N, Saggioro F, Neder L, Machado HR, Silva Jr WA, Moreira AC, Castro M 2009 MicroRNAs differentially expressed in ACTH-secreting pituitary tumors. J Clin Endocrinol Metab 94:320-323
11. Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D, Vignali C, Calin GA, Negrini M, Croce CM, Degli Uberti EC 2007 Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol 210:370-377
12. Morris DG, Kola B, Grossman AB, Korbonits M, The optimal endogenous control for human pituitary RNA gene expression studies. Program of the 85th Annual Meeting of The Endocrine Society, Philadelphia, PA, 2003 (Abstract P2-672)
13. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS 2004 Human MicroRNA targets. PLoS Biol 2:e363
14. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB 2003 Prediction of mammalian microRNA targets. Cell 115:787-798
15. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N 2005 Combinatorial microRNA target predictions. Nat Genet 37: 495-500
16. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I 2006 A pattern-based method for the identification of microRNA-target sites and their corresponding RNA/RNA complexes. Cell 126:1203-1217
17. Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J, Garcia S, Nowak J, Yeung ML, Jeang KT, Chaix A, Fazli L, Motoo Y, Wang Q, Rocchi P, Russo A, Gleave M, Dagorn JC, Iovanna JL, Carrier A, Pébusque MJ, Dusetti NJ 2007 Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci USA 104:16170-16175
18. Butz H, Likó I, Boyle B, Lendvai N, Igaz P, Czirják S, Korbonits M, Rácz K, Patócs A 2009 [Methods of microRNA research and their use in pituitary adenomas]. J Hungarian Soc Intern Med 62:355-362 (Hungarian)
19. Butz H, Likó I, Boyle B, Czirják S, Igaz P, Patócs A, Rácz K, MicroRNA expression in human sporadic pituitary adenomas. Presented at 11th European Congress of Endocrinology, Istanbul, Turkey, 2009 (Abstract 13 S9)
20. Qi J, Yu JY, Shcherbata HR, Mathieu J, Wang AJ, Seal S, Zhou W, Stadler BM, Bourgin D, Wang L, Nelson A, Ware C, Raymond C, Lim LP, Magnus J, Ivanovska I, Diaz R, Ball A, Cleary MA, Ruohola-Baker H 2009 MicroRNAs regulate human embryonic stem cell division. Cell Cycle 8:3729-3741
21. KawabeT2004G2checkpoint abrogators as anticancer drugs. Mol Cancer Ther 3:513-519
22. Murrow LM, Garimella SV, Jones TL, Caplen NJ, Lipkowitz S 2010 Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome Breast Cancer Res Treat 122:347-357
23. Niida H, Tsuge S, Katsuno Y, Konishi A, Takeda N, Nakanishi M 2005 Depletion of Chk1 leads to premature activation of Cdc2-cyclin B and mitotic catastrophe. J Biol Chem 280:39246-39252
24. Scheffner M, Münger K, Byrne JC, Howley PM 1991 The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88:5523-5527
25. Faraoni I, Antonetti FR, Cardone J, Bonmassar E 2009 miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792:497-505
26. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca EA, Lawler S 2008 Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA- 128 inhibits glioma proliferation and self-renewal. Cancer Res 68:9125-9130
27. Foekens JA, Sieuwerts AM, Smid M, Look MP, de Weerd V, Boersma AW, Klijn JG, Wiemer EA, Martens JW 2008 Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor- positive human breast cancer. Proc Natl Acad Sci USA 105: 13021-13026
28. Evangelisti C, Florian MC, Massimi I, Dominici C, Giannini G, Galardi S, Buè MC, Massalini S, McDowell HP, Messi E, Gulino A, Farace MG, Ciafrè SA2009 MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. FASEB J 23:4276-4287
29. Zhang Y, Chao T, Li R, Liu W, Chen Y, Yan X, Gong Y, Yin B, Liu W, Qiang B, Zhao J, Yuan J, Peng X 2009 MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med 87:43-51
30. Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J, Stolbrink M, Christian HC, Wray J, Bishop-Bailey D, Berney DM, Wass JA, Popovic V, Ribeiro-Oliveira Jr A, Gadelha MR, Monson JP, Akker SA, Davis JR, Clayton RN, Yoshimoto K, Iwata T, Matsuno A, Eguchi K, Musat M, Flanagan D, Peters G, Bolger GB, Chapple JP, Frohman LA, Grossman AB, Korbonits M 2008 The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 93:2390-2401
31. Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD, Pertsemlidis A 2009 miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res 7:1234-1243
32. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE, Green AR, Ellis IO, Tavaré S, Caldas C, Miska EA 2007 MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 8:R214
33. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M 2009 Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 34:1069-1075
34. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y 2009 Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 24: 652-657
35. Yu Z, Wang C, Wang M, Li Z, Casimiro MC, Liu M, Wu K, Whittle J, Ju X, Hyslop T, McCue P, Pestell RG 2008 A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol 182:509-517
36. Poliseno L, Pitto L, Simili M, Mariani L, Riccardi L, Ciucci A, Rizzo M, Evangelista M, Mercatanti A, Pandolfi PP, Rainaldi G 2008 The proto-oncogene LRF is under post-transcriptional control of MiR- 20a: implications for senescence. PLoS One 3:e2542
37. Ebi H, Sato T, Sugito N, Hosono Y, Yatabe Y, Matsuyama Y, Yamaguchi T, Osada H, Suzuki M, Takahashi T 2009 Counter-balance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers. Oncogene 28:3371-3379
38. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT 2005 c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435:839-843
39. Pickering MT, Stadler BM, Kowalik TF 2009 miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression. Oncogene 28:140-145
40. Lin SL, Chang D, Wu DY, Ying SY 2003 A novel RNA splicing-mediated gene silencing mechanism potential for genome evolution. Biochem Biophys Res Commun 310:754-760